Fuller & Thaler Asset Management’s AbbVie ABBV Stock Holding History

Fuller & Thaler Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-10,600	Closed	-$982K	–	455
2018 Q2	$982K	Hold	10,600	–	–	0.01%	329
2018 Q1	$1M	Sell	10,600 -3,800	-26%	-$417K	0.01%	324
2017 Q4	$1.39M	Hold	14,400	–	–	0.02%	293
2017 Q3	$1.28M	Sell	14,400 -1,000	-6%	-$76.1K	0.02%	275
2017 Q2	$1.12M	Buy	15,400 +4,400	+40%	+$296K	0.01%	276
2017 Q1	$717K	Hold	11,000	–	–	0.01%	281
2016 Q4	$689K	Hold	11,000	–	–	0.01%	275
2016 Q3	$694K	Buy	11,000 +1,600	+17%	+$104K	0.01%	258
2016 Q2	$582K	Hold	9,400	–	–	0.01%	266
2016 Q1	$537K	Buy	+9,400	New	+$524K	0.01%	268
2015 Q3	–	Sell	-18,600	Closed	-$1.25M	–	659
2015 Q2	$1.25M	Buy	18,600 +1,100	+6%	+$71.8K	0.04%	252
2015 Q1	$1.02M	Sell	17,500 -14,000	-44%	-$846K	0.03%	267
2014 Q4	$2.06M	Buy	31,500 +9,500	+43%	+$599K	0.07%	208
2014 Q3	$1.27M	Sell	22,000 -5,300	-19%	-$294K	0.05%	247
2014 Q2	$1.54M	Sell	27,300 -6,400	-19%	-$336K	0.07%	235
2014 Q1	$1.73M	Buy	+33,700	New	+$1.7M	0.08%	217

Other funds holding ABBV

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Fuller & Thaler Asset Management's ABBV Position: Q3 2018 in Review

Fuller & Thaler Asset Management sold out of AbbVie (ABBV) in Q3 2018, closing a stake of 10,600 shares — an estimated $982K sold.

Fuller & Thaler Asset Management first reported a position in ABBV in Q1 2014 and held it in 16 quarters. The position peaked at $2.06M in Q4 2014. 1,956 funds tracked by Wall St. Rank hold ABBV as of Q3 2018.

Fuller & Thaler Asset Management reported no remaining AbbVie position as of Q3 2018 after selling out during the quarter.
Fuller & Thaler Asset Management sold 10,600 AbbVie shares in Q3 2018, an estimated $982K.
Fuller & Thaler Asset Management first reported a position in AbbVie in Q1 2014 and held it in 16 quarters.
Fuller & Thaler Asset Management's AbbVie position peaked at $2.06M in Q4 2014.
1,956 funds tracked by Wall St. Rank held AbbVie as of Q3 2018.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2018, filed 13 Nov 2018.